News · 26 weeks112+400%
2025-11-022026-04-26
Mix7890d
- Insider54(69%)
- SEC Filings10(13%)
- Other9(12%)
- Earnings3(4%)
- Leadership1(1%)
- Dividends1(1%)
Latest news
25 items- SECSEC Form CERT filed by Danaher CorporationCERT - DANAHER CORP /DE/ (0000313616) (Filer)
- SECSEC Form 8-A12B filed by Danaher Corporation8-A12B - DANAHER CORP /DE/ (0000313616) (Filer)
- SECSEC Form 8-K filed by Danaher Corporation8-K - DANAHER CORP /DE/ (0000313616) (Filer)
- PRWhy Medtech Giants Are Quietly Paying Up for AI DiagnosticsISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD.VANCOUVER, BC, April 29, 2026 /CNW/ -- USANewsGroup.com News Commentary – There's a quiet bidding war underway for AI diagnostics, and the price keeps climbing. The global AI in medical imaging market is on track to hit $2.20 billion in 2026, with a 34.8% growth rate baked in through 2033[1]. Q1 2026 healthcare M&A activity tells the same story: capital is rotating into AI-enabled platforms that already carry regulatory clearance, recurring revenue, and real clinical data behind them[2]. That description fits a short list of names worth knowing right now: VentriPoint Diagnostics (TSXV:VPT) (OTCPK: VPTDF), Medtronic (NYSE:MDT), Danaher (NYSE:DHR
- INSIDERSEC Form 4 filed by Director Sanders A Shane4 - DANAHER CORP /DE/ (0000313616) (Issuer)
- INSIDERSEC Form 4 filed by Director Stevens Raymond C4 - DANAHER CORP /DE/ (0000313616) (Issuer)
- INSIDERSEC Form 4 filed by Director List Teri4 - DANAHER CORP /DE/ (0000313616) (Issuer)
- INSIDERSEC Form 4 filed by Director Zerhouni Elias A.4 - DANAHER CORP /DE/ (0000313616) (Issuer)
- INSIDERSEC Form 4 filed by Director Dewan Feroz4 - DANAHER CORP /DE/ (0000313616) (Issuer)
- INSIDERSEC Form 4 filed by Director Filler Linda4 - DANAHER CORP /DE/ (0000313616) (Issuer)
- INSIDERSEC Form 4 filed by Director Spoon Alan G4 - DANAHER CORP /DE/ (0000313616) (Issuer)
- PRCD&R Announces Jim Lico, Former Fortive CEO, as Operating AdvisorCD&R (or the "Firm") today announced that Jim Lico, former President and Chief Executive Officer of Fortive Corporation (NYSE:FTV), a diversified industrial growth company, has been engaged as an Operating Advisor to CD&R funds. Jim will work with the Firm's industrials team to help source new investments and advise the funds' industrials businesses. Jim served as founding President and CEO of Fortive from 2016 to 2025, leading the company's separation from Danaher Corporation (NYSE:DHR), growing its market capitalization from $16 billion to $25 billion and delivering safety and productivity solutions across the industrial and healthcare sectors. During his tenure, Fortive delivered stron
- SECSEC Form 424B5 filed by Danaher Corporation424B5 - DANAHER CORP /DE/ (0000313616) (Filer)
- PRDanaher Announces Pricing of Euro-Denominated Senior Notes OfferingWASHINGTON, April 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today that it has priced an offering of the following euro-denominated senior notes (the "Offering"): €500,000,000 principal amount of floating rate senior notes due 2028 at an offering price of 100.000% of the principal amount;€750,000,000 principal amount of 3.250% senior notes due 2030 at an offering price of 99.934% of the principal amount;€750,000,000 principal amount of 3.625% senior notes due 2034 at an offering price of 99.918% of the principal amount; and€1,000,000,000 principal amount of 4.000% senior notes due 2038 at an offering price of 99.953% of the principal amount (collectively, t
- SECSEC Form FWP filed by Danaher CorporationFWP - DANAHER CORP /DE/ (0000313616) (Subject)
- SECSEC Form 424B5 filed by Danaher Corporation424B5 - DANAHER CORP /DE/ (0000313616) (Filer)
- PRDanaher Reports First Quarter 2026 ResultsWASHINGTON, April 21, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2026. All results in this release reflect only continuing operations and period-to-period comparisons are year-over-year unless otherwise noted. Key First Quarter 2026 ResultsNet earnings were $1.0 billion, or $1.45 per diluted common share.Non-GAAP adjusted diluted net earnings per common share grew 9.5% to $2.06.Revenues increased 3.5% year-over-year to $6.0 billion and non-GAAP core revenue increased 0.5% year-over-year.Operating cash flow was $1.3 billion and non-GAAP free cash flow was $1.1 billion.Strong Q1 earnings performance enabling increased full year 2026 adju
- SECDanaher Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement8-K - DANAHER CORP /DE/ (0000313616) (Filer)
- PRBeckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 MinutesModeling Shows Adoption of New Access MeMed BV Assay Could Cut up to €80M in Avoidable Costs across European Health Systems through Fewer Unnecessary Admissions and Testing BREA, Calif., April 13, 2026 /PRNewswire/ -- Beckman Coulter Diagnostics, a Danaher company and global leader in clinical diagnostics, today announced it has received CE 2797 mark under IVDR for the Access MeMed BV assay, enabling broad availability of a high-throughput host‑response test that helps clinicians differentiate between bacterial and viral infections in approximately 20 minutes. Validated for use
- PRAI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost AdvantagesAUSTIN, Texas, April 09, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: As regulatory demands intensify and production environments become more complex, pharmaceutical manufacturers are shifting beyond traditional quality assurance systems toward a new operational model: integrating artificial intelligence directly into manufacturing workflows as a continuous compliance layer. Rather than depending on retrospective audits and manual checks, AI-driven technologies are now capable of monitoring, validating and optimizing production processes in real time to ensure alignment with evolving Good Manufacturing Practice (GMP) requirements. This transformation is becoming increasingly vis
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Danaher CorporationSCHEDULE 13G/A - DANAHER CORP /DE/ (0000313616) (Subject)
- SECSEC Form DEFA14A filed by Danaher CorporationDEFA14A - DANAHER CORP /DE/ (0000313616) (Filer)
- SECSEC Form DEF 14A filed by Danaher CorporationDEF 14A - DANAHER CORP /DE/ (0000313616) (Filer)
- PRDanaher Schedules First Quarter 2026 Earnings Conference CallWASHINGTON, March 20, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2026 on Tuesday, April 21, 2026 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call.You ca
- INSIDERExecutive Vice President Riley Christopher Paul was granted 6,172 shares and covered exercise/tax liability with 1,115 shares, increasing direct ownership by 33% to 20,400 units (SEC Form 4)4 - DANAHER CORP /DE/ (0000313616) (Issuer)
DHR FAQ
6 questionsWhat does Danaher Corporation do?
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and...Where does DHR stock trade?
Danaher Corporation (DHR) is listed on NYSE.What sector and industry is DHR in?
Danaher Corporation operates in the Industrials sector, Industrial Machinery/Components industry.What are analysts saying about DHR?
Danaher Corporation has had 8 recent analyst actions on file. The most recent action was from Goldman: Buy on 2025-12-09.What companies are similar to DHR?
Notable peers in the same industry include ASML (ASML Holding N.V. New York Registry Shares), LRCX (Lam Research Corporation), TMO (Thermo Fisher Scientific Inc), ETN (Eaton Corporation PLC), DE (Deere & Company). Compare DHR side-by-side with any of them on Quantisnow.How can I track DHR on Quantisnow?
Quantisnow aggregates Danaher Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow DHR to receive live email and push alerts on every new disclosure.